Thalidomide for the treatment of refractory necrobiosis lipoidica
Arch Dermatol
.
2006 Jan;142(1):20-2.
doi: 10.1001/archderm.142.1.20.
Authors
Tarun Kukreja
1
,
Jeffrey Petersen
Affiliation
1
Center for Dermatological and Cosmetic Surgery, Washington University, St Louis, MO 63141, USA. tkukreja@gmail.com
PMID:
16415381
DOI:
10.1001/archderm.142.1.20
No abstract available
Publication types
Case Reports
MeSH terms
Angiogenesis Inhibitors / therapeutic use*
Female
Follow-Up Studies
Humans
Middle Aged
Necrobiosis Lipoidica / drug therapy*
Thalidomide / therapeutic use*
Substances
Angiogenesis Inhibitors
Thalidomide